Sort
39,280 grants matching “leukemia”
Targeted aberrant signaling in CBL-mutant leukemia
$388,111Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2021 · CA
A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer
$388,026Eric J Duncavage · Washington University · R33 · FY2023 · CA
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
$388,013Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$388,003Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2022 · CA
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$387,997Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2021 · CA
New Theraputics for Graft-Versus-Host Disease
$387,982Krishna Kumar · Chemokine Pharmaceutical, Inc. · R43 · FY2006 · AI
New Theraputics for Graft-Versus-Host Disease
$387,982Mi Youn Lim · Chemokine Pharmaceutical, Inc. · R43 · FY2007 · AI
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
$387,981Jose R Conejo-Garcia · Duke University · R01 · FY2023 · CA
Molecular Basis of Drosophila Homeotic Gene Regulation
$387,936Case Western Reserve University · R01 · FY2004 · GM
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$387,868James Kim · Ut Southwestern Medical Center · R01 · FY2025 · CA
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
$387,863Jian Huang · Coriell Institute For Medical Research · R01 · FY2024 · CA
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
$387,837Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2010 · DK
Arsenic-induced apoptosis in myeloma
$387,826Lawrence H Boise · Emory University · R01 · FY2010 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$387,823Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia
$387,823Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2023 · CA
Role of Abl Kinases in immune cell signaling
$387,789Ann Marie Pendergast · Duke University · R01 · FY2014 · AI
Role of Abl Kinases in immune cell signaling
$387,789Ann Marie Pendergast · Duke University · R01 · FY2015 · AI
Role of Abl Kinases in immune cell signaling
$387,789Ann Marie Pendergast · Duke University · R01 · FY2012 · AI
Validating Syk as a Target for AML Therapy
$387,775Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2014 · CA
E2A AS A POTENTIAL TUMOR SUPPRESSOR
$387,731University Of California San Diego · R01 · FY2002 · CA
Function and targeting of a stable transcription factor complex in leukemia
$387,731Robert G Roeder · Rockefeller University · R01 · FY2021 · CA
Function and targeting of a stable transcription factor complex in leukemia
$387,731Robert G Roeder · Rockefeller University · R01 · FY2020 · CA
Validating Syk as a Target for AML Therapy
$387,731Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Altered Communication between the nucleus and the mitochondria under oncogenic states
$387,731Michael P Rout · Rockefeller University · R01 · FY2021 · CA
Transcriptional Mechanism of BRD4 in Solid Tumor
$387,731Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA